CEACAM5 and colorectal carcinoma: At present, NCCN guidelines recommend that carcinoembryonic antigen (CEA) and conventional imaging examinations (Ultrasonography, enhanced MRI, enhanced CT, etc.)should be used to monitor recurrence and metastasis in patients with CRC.